Advanced search
2 files | 405.55 KB Add to list

Predicting the outcome of ankylosing spondylitis therapy

Author
Organization
Keywords
Immunology, Biochemistry, Genetics and Molecular Biology(all), Immunology and Allergy, Rheumatology, DISEASE-ACTIVITY INDEX, NECROSIS FACTOR TREATMENT, PLACEBO-CONTROLLED TRIAL, MAJOR CLINICAL-RESPONSE, ACTIVITY SCORE ASDAS, ANTI-TNF THERAPY, INFLIXIMAB, SAFETY, EPIDEMIOLOGY, IMPROVEMENT

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 360.13 KB
  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 45.41 KB

Citation

Please use this url to cite or link to this publication:

MLA
Vastesaeger, Nathan et al. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” ANNALS OF THE RHEUMATIC DISEASES 70.6 (2011): 973–981. Print.
APA
Vastesaeger, N., van der Heijde, D., Inman, R. D., Wang, Y., Deodhar, A., Hsu, B., Rahman, M. U., et al. (2011). Predicting the outcome of ankylosing spondylitis therapy. ANNALS OF THE RHEUMATIC DISEASES, 70(6), 973–981.
Chicago author-date
Vastesaeger, Nathan, Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, et al. 2011. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” Annals of the Rheumatic Diseases 70 (6): 973–981.
Chicago author-date (all authors)
Vastesaeger, Nathan, Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, Ben Dijkmans, Piet Geusens, Bert Vander Cruyssen, Eduardo Collantes, Joachim Sieper, and Jürgen Braun. 2011. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” Annals of the Rheumatic Diseases 70 (6): 973–981.
Vancouver
1.
Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, et al. Predicting the outcome of ankylosing spondylitis therapy. ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):973–81.
IEEE
[1]
N. Vastesaeger et al., “Predicting the outcome of ankylosing spondylitis therapy,” ANNALS OF THE RHEUMATIC DISEASES, vol. 70, no. 6, pp. 973–981, 2011.
@article{8500055,
  author       = {Vastesaeger, Nathan and van der Heijde, Désirée and Inman, Robert D and Wang, Yanxin and Deodhar, Atul and Hsu, Benjamin and Rahman, Mahboob U and Dijkmans, Ben and Geusens, Piet and Vander Cruyssen, Bert and Collantes, Eduardo and Sieper, Joachim and Braun, Jürgen},
  issn         = {0003-4967},
  journal      = {ANNALS OF THE RHEUMATIC DISEASES},
  keywords     = {Immunology,Biochemistry,Genetics and Molecular Biology(all),Immunology and Allergy,Rheumatology,DISEASE-ACTIVITY INDEX,NECROSIS FACTOR TREATMENT,PLACEBO-CONTROLLED TRIAL,MAJOR CLINICAL-RESPONSE,ACTIVITY SCORE ASDAS,ANTI-TNF THERAPY,INFLIXIMAB,SAFETY,EPIDEMIOLOGY,IMPROVEMENT},
  language     = {eng},
  number       = {6},
  pages        = {973--981},
  title        = {Predicting the outcome of ankylosing spondylitis therapy},
  url          = {http://dx.doi.org/10.1136/ard.2010.147744},
  volume       = {70},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: